Navigation Links
Medela Announces 2011 Virtual Human Milk Collection Campaign Award Recipients
Date:12/19/2011

MCHENRY, Ill., Dec. 19, 2011 /PRNewswire/ -- Medela announced today the winning neonatal intensive care units (NICUs) from its Virtual Human Milk (breastmilk) Collection Campaign in honor of prematurity awareness and the 500,000 families impacted by premature births each year. In support of the March of Dimes' National Prematurity Awareness Month, several thousand participants across the U.S. voted for their preferred NICU to win Medela products for their facility.

Each of the six following award recipients will receive $5,000 in neonatal human milk support products from Medela, including Symphony® Preemie+ program cards, Symphony breastpumps, Waterless Milk Warmers™, Transport/Discharge Bags and/or BabyWeigh II™ scales:

  • New Hanover Regional Medical Center in Wilmington, N.C.
  • Children's Hospital of Wisconsin in Milwaukee, Wis.
  • Saint Vincent Health Center in Erie, Pa.
  • Baptist Medical Center East in Montgomery, Ala.
  • St. Joseph Mercy Hospital in Oakland, Mich.
  • Dallas Methodist Medical Center in Dallas, Texas
  • "Our goals for this campaign are to help raise awareness of the importance of human milk and support mothers and healthcare professionals to successfully provide breastmilk to babies in the NICU who need it most," said Carolin Archibald, president of Medela. "The value of breastmilk is immeasurable for the health benefits it provides infants in the NICU. Breastmilk is nature's medicine, protecting premature babies from serious complications and infections during and after their hospital stay."

    A full-term pregnancy is 40 weeks. In the U.S., more than half a million babies are born premature, prior to 37 weeks of gestation. Premature birth is a serious health issue in the U.S. and for impacted families. Premature babies have a higher risk for health complications, and most require care in a NICU. NICUs play a vital role in the survival and care of premature babies as they have specialized medical expertise and equipment to handle the multiple complications faced by premature infants and their families. Medela's donations will help to provide NICU products to support premature babies and breastfeeding.

    Research shows that infants who receive more breastmilk feedings have better health outcomes. Feeding human milk rather than formula in the NICU has shown to reduce the length of hospital stay, days of oxygen therapy needed, and the incidence of late onset sepsis, necrotizing enterocolitis (NEC), ear infections, serious respiratory tract infections and gastroenteritis.

    For more information about the campaign, please visit www.medelapreemieawareness.com.

    About MedelaMedela provides the most technologically advanced breastpumps and breastfeeding accessories to nursing mothers around the world. A long-time champion of breastfeeding, Medela is the only company to develop products based on research by the world's leading lactation experts. As a result, Medela's breastpumps are the number one choice of healthcare professionals and facilities worldwide.

    Medela has developed an extensive line of products to meet the diverse needs of nursing mothers.  These products include hospital-grade, double and single electric and manual personal breastpumps; breastfeeding accessories such as breast care products and specialty feeding devices. Most recently, Medela introduced 2-Phase Expression®, the only research-based breastpump technology that mimics a baby's nursing rhythm, resulting in faster let-down and milk flow.

    Founded in 1961 by Olle Larsson in Zug, Switzerland, Medela continues to grow under the ownership of the Larsson family. Medela serves customers through a worldwide network of distribution partners in more than 90 countries and its 15 subsidiaries in Australia, the Benelux countries, Canada, China, France, Germany, Italy, Japan, Russia, the United Kingdom, the United States, Spain, Sweden, Poland and Switzerland. www.medela.com

    Media Contacts: Kathy Kolet

    Amanda DaliaMedela, Inc.

    Feinstein Kean Healthcare815-578-2232

    617-761-6725kathy.kolet@medela.com 

    amanda.dalia@fkhealth.com  


    '/>"/>

    SOURCE Medela
    Copyright©2010 PR Newswire.
    All rights reserved

    Related medicine technology :

    1. Medela Recognizes National Prematurity Awareness Month With Virtual Human Milk Collection Campaign
    2. Medela Announces Virtual Human Milk Collection Campaign Award Recipients in Honor of 2009 Prematurity Awareness Month
    3. Medela Helps Employers Create Supportive Environment for Breastfeeding
    4. Medela Announces Virtual Human Milk Collection Campaign Award Recipients in Honor of 2010 Prematurity Awareness Month
    5. Medela Announces 2011 Breastfeeding Hall of Excellence Inductees to Nationally Recognize Exceptional Breastfeeding Advocates
    6. Medela Announces Virtual Breast Milk Collection Campaign in Honor of Prematurity Awareness Month
    7. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
    8. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
    9. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
    10. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
    11. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:2/17/2017)... Cryoablation, Electrical, Endometrial Hydrothermal, Laser/Light, Microwave, Radiofrequency, Ultrasound, Cardiovascular, Gynaecology, ... expected to grow at a CAGR of 9.4% from 2017-2022 and ... at a CAGR of 9.5% from 2017 to 2027. The market ... ... benefit you Read on to discover how you can exploit ...
    (Date:2/17/2017)... 2017 Arvinas LLC, a private biotechnology company ... degradation, today announced the presentation of new preclinical data ... poster session at the American Society of Clinical Oncology ... Orlando, FL. "The new ... the potential of PROTACs to drive durable and robust ...
    (Date:2/17/2017)... and Markets has announced the addition of the "Pharmaceutical Contract Manufacturing ... ... the US, Canada , Japan , ... of World. Annual estimates and forecasts are provided for the period 2015 ... Market data and analytics are derived from primary and secondary research. ...
    Breaking Medicine Technology:
    (Date:2/17/2017)... FL (PRWEB) , ... February 17, 2017 , ... ... software tools that allow for the electronic prescribing of controlled and non-controlled substances ... , Ninety percent of pharmacies in the United States now accept electronic prescriptions, ...
    (Date:2/17/2017)... ... February 17, 2017 , ... Empowering each person's mental functions, ... each and every seminar, session and class she offers. At the International ... which help energize creativity, focus mental functions, enhance athletic focus and skill sets, ...
    (Date:2/17/2017)... , ... February 17, 2017 , ... ... the HIMSS17 Conference & Exhibition in Orlando, Fla., February 19-23. Visitors to the ... the most widely used electronic patient signatures solution in healthcare . ...
    (Date:2/17/2017)... ... February 17, 2017 , ... Pharmica Consulting attended ... all facets of clinical trial planning and management. Pharmica discussed the importance of ... In addition, attendees stopping by Pharmica’s booth were able to demo its cloud-based ...
    (Date:2/17/2017)... ... 17, 2017 , ... Like most hospitals across the nation, Onslow Memorial Hospital ... the Hospital Readmission Reduction Program (HRRP), the return of a patient to the hospital ... the nation. While many providers are struggling to leverage limited resources and technology, Onslow ...
    Breaking Medicine News(10 mins):